EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany

Christian Taube, Timm Greulich, Sebastian Böing, Oliver Pfaar, Martin Wagenmann iD, Sven Becker, Mathias Sulk, Niklas J Gerkau, Jan Claudius Schwitalla, Tim Vierbuchen iD

Clinical and Translational Allergy · 2026-07 · 16 (7)

DOI: 10.1002/clt2.70187 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical and Translational Allergy, online erschienen am 09.07.2026. Verfasst von Christian Taube und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, Essen, Germany. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parenteral depot corticosteroids (PDCs) continue to be prescribed for allergic and respiratory diseases, despite clear guideline recommendations against their use. This clinical practice raises significant safety concerns. We analyzed current PDC use in Germany and characterized prescribing patterns.

Methods

Retrospective analysis of anonymized, longitudinal prescription data (IQVIA LRx) and evaluation of anonymized electronic medical record (EMR) data (IQVIA Disease Analyzer) from October 2023 to September 2024. Data were stratified by diagnosis, prescription frequency, prescriber specialty, region, age group and comorbidities.

Results

The analysis of prescription data revealed that 9984 asthma and 5279 chronic obstructive pulmonary disease (COPD) patients received at least one PDC injection annually by general practitioners, which are the predominant prescribers. Of these patients, the majority received a single prescription. Regional differences were observed with particularly high prescription rates in western regions such as Rhineland‐Palatinate and Saarland. Monthly PDC prescription rates follow seasonal patterns of most common pollen allergens. Furthermore, over 23,000 patients with rhinopathy but without asthma or COPD received at least one prescription as well as approximately 3700 patients with chronic sinusitis with or without nasal polyps but no asthma or COPD.

Conclusion

PDCs continue to be administered to a relevant number of patients with asthma, COPD, and upper airway diseases despite clear guideline recommendations against systemic steroid treatment. The injection frequency, as well as the association with allergic comorbidities and seasonal patterns are compatible with the treatment of seasonal allergies. This underscores the need for targeted educational initiatives and stronger implementation of guideline‐adherent therapies.

Schlagwörter

Stichwörter der Autor:innen

COPDGermanyallergic rhinitisasthmaparenteral depot corticosteroids

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, Essen, Germany.
  • Department of Respiratory, Intensive Care, and Sleep Medicine, Marburg University, Member of the German Centre for Lung Research (DZL), Marburg, Germany.
  • PneumoPraxis Marburg, Marburg, Germany.
  • Schwerpunktpraxis Lungen- und Bronchialheilkunde, Allergologie und Schlafmedizin, Meerbusch, Germany.
  • Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Department of Otorhinolaryngology, Düsseldorf University Hospital (UKD), Düsseldorf, Germany.

ORCID-Profile: Martin Wagenmann, Tim Vierbuchen

Förderung

  • AstraZeneca Germany

Zitieren

APA

Taube, C., Greulich, T., Böing, S., Pfaar, O., Wagenmann, M., Becker, S., Sulk, M., Gerkau, N. J., Schwitalla, J. C., & Vierbuchen, T. (2026). Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany. Clinical and Translational Allergy, 16(7). https://doi.org/10.1002/clt2.70187

Vancouver

Taube C, Greulich T, Böing S, Pfaar O, Wagenmann M, Becker S, et al. Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany. Clinical and Translational Allergy. 2026;16(7). doi:10.1002/clt2.70187

BibTeX
@article{Taube2026,
  author = {Taube, Christian and Greulich, Timm and Böing, Sebastian and Pfaar, Oliver and Wagenmann, Martin and Becker, Sven and Sulk, Mathias and Gerkau, Niklas J and Schwitalla, Jan Claudius and Vierbuchen, Tim},
  title = {Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany},
  journal = {Clinical and Translational Allergy},
  year = {2026},
  volume = {16},
  number = {7},
  doi = {10.1002/clt2.70187}
}
Kostenlos starten →